Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial
| Image |  |
|---|---|
| Description | scientific article published on 20 April 2020 |
| Author/s |
author: Razelle Kurzrock Vivek Subbiah |
| Publication date | April 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |